Phoenix Neurological Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2013
NCT02483845
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now